Severe outcome of juvenile idiopathic arthritis (JIA) associated with familial Mediterranean fever (FMF)

Clinical and Experimental Rheumatology

Volumn 22, Issue 4 SUPPL. 24, 2004, Pages

  Rozenbaum, Michael ^a,b,c   Rosner, Itzhak ^a,c  

^a BNAI ZION MEDICAL CENTER   (Israel)

^b Zvulon Clinic   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

FMF; JIA; M694V mutation; MEFV; Poor prognosis

Indexed keywords

ALENDRONIC ACID; AURANOFIN; CALCIUM; COLCHICINE; GENE PRODUCT; GLUCOCORTICOID; GOLD SALT; HYDROXYCHLOROQUINE; MARENOSTRIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; PYRIN; SALAZOSULFAPYRIDINE; SALICYLIC ACID; UNCLASSIFIED DRUG; VITAMIN D; SALICYLIC ACID DERIVATIVE; INDOMETACIN; PREDNISOLONE; CYTOSKELETON PROTEIN; PROTEIN;

ADULT; AMYLOIDOSIS; ARTHROPATHY; ARTICLE; BONE NECROSIS; CASE REPORT; CHILD; COHORT ANALYSIS; COMORBIDITY; DEATH; DISEASE ASSOCIATION; DISEASE SEVERITY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; GENE MUTATION; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY FAILURE; LOW FAT DIET; MALE; MALE INFERTILITY; NORTH AFRICA; ONSET AGE; OUTCOMES RESEARCH; POLYARTHRITIS; PRIORITY JOURNAL; PROGNOSIS; SMALL INTESTINE OBSTRUCTION; SMALL INTESTINE RESECTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT INDICATION; ABDOMINAL PAIN; ANEMIA; ARTHRITIS; CLINICAL FEATURE; DIET RESTRICTION; DISEASE DURATION; DRUG EFFICACY; DRUG RESPONSE; ERYTHROCYTE SEDIMENTATION RATE; GENE; HAND PAIN; HIP DISLOCATION; HOMOZYGOSITY; HUMERUS FRACTURE; JOINT BIOPSY; LAPAROTOMY; MEFV GENE; MORNING STIFFNESS; NORMOCHROMIC NORMOCYTIC ANEMIA; NORTH AFRICAN; PROTEINURIA; RECURRENT FEVER; SYNOVITIS; TREATMENT DURATION; VITAMIN SUPPLEMENTATION; WRIST PAIN; CAUSE OF DEATH; FEMUR HEAD NECROSIS; HISTOPATHOLOGY; INFERTILITY; INTESTINE SURGERY; NEGRO; PATHOGENESIS; FATALITY; GENETICS; HIP ARTHROPLASTY; INFANT; MUTATION; PATHOLOGY; PRESCHOOL CHILD;

ARTHRITIS, JUVENILE RHEUMATOID; ARTHROPLASTY, REPLACEMENT, HIP; CHILD; CHILD, PRESCHOOL; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; FATAL OUTCOME; FEMALE; HUMANS; INFANT; MALE; MUTATION; PROGNOSIS; PROTEINS;

EID: 5444222960     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. SOHAR E, GAFNI J, PRAS M, HELLER H: Familial Mediterranean Fever: a survey of 470 cases and review of the literature. Am J Med 1967; 43: 227-53.
2. DANIELS M, SHOHAT T, BRENNER-ULLMAN A et al.: Familial Mediterranean Fever: High gene frequency among the non-Ashkenazic and Ashkenazic Jewish population in Israel. Am J Med Genet 1995; 55: 311-4.
3. ROZENBAUM M, MARCOVICI O, ROSNER I: FMF in Druze of North Israel. In SOHAR E, GAFNI J and PRAS M (Eds.): Familial Mediterranean Fever, Tel Aviv, Freund Publishing 1997: 60-1.
4. LIVNEH A, LANGEVITZ P, ZEMER D et al.: The changing face of familial Mediterranean fever. Semin Arthritis Rheum 1996; 26: 612-27.
5. ESHEL G, ZEMER D, BAR YOCHAI A: Acute orchitis in Familial Mediterranean Fever. Ann Intern Med 1998; 109: 164-5.
6. ZEMER D, REVACH M, PRAS M et al.: A controlled trial of colchicine in preventing attacks of Familial Mediterranean Fever. N Engl J Med 1974; 291: 932-4.
7. ZEMER D, PRAS M, SOHAR E, MODAN M, CABILI S, GAFNI J: Colchicine in the prevention and treatment of the amyloidosis of Familial Mediterranean Fever. N Eng J Med 1986; 314: 1001-5.
8. The French FMF Consortium: A candidate gene for Familial Mediterranean Fever. Nat Genet 1997; 17: 25-31.
9. The International FMF Consortium: Ancient missense mutations in a new member of the RoRet gene family are likely to cause Familial Mediterranean Fever. Cell 1997; 90: 797-807.
10. SCHWARTZ T, LANGEVITZ P, ZEMER D, GAZIT E, PRAS M, LIVNEH A: Behçet's Disease in Familial Mediterranean Fever: Characterization of the association between the two diseases. Semin Arthritis Rheum 2000; 29: 286-95.
11. OZEN S, BEN CHETRIT E, BAKKALOGLU A et al.: Familial Mediterranean Fever and polyarteritis nodosa: is it an association? Arthritis Rheum 2000; 43 (Suppl.): 1376.
12. OZYILKAN E, SIMSEK H, TELATAR H: Absence of asthma in patients with familial Mediterranean Fever. Isr J Med Sci 1994; 30: 237-8.
13. DANON YL, LAOR A, SHLEZINGER M, ZEMER D: Decreased incidence of asthma in patients with Familial Mediterranean Fever. Is J Med Sci 1990: 26: 459-60.
14. PETTY RE, SOUTHWOOD TR, BAUM J et al.: Revision of the proposed classification criteria for Juvenile Idiopathic Arthritis: Durban, 1997. J Rheumatol 1998; 25: 1991-4.
15. LIVNEH A, LANGEVITZ P, ZEMER D et al.: Criteria for the diagnosis of Familial Mediterranean Fever. Arthritis Rheum 1997; 40: 1879-85.
16. MAJEED HA, RAWASHDEH M: The clinical patterns of arthritis in children with familial Mediterranean fever. QJM 1997; 90: 37-43.
17. SUKENIK S, HOROVITZ J, BOEHM R, BARZIV J: Cervical involvement in Familial Mediterranean Fever. J Rheumatol 1985; 12: 603-4.
18. LAIFO K, KAARELA K, KAUPPI M: Cervical spine disorders in patients Wth rheumatoid arthritis and amyloidosis. Clin Rheumatol 2002; 3: 227-30.
19. DEWALLE M, DOMINGO C, ROZENBAUM M et al.: Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Gen 1998; 6: 95-7.
20. BEN-CHETRIT E, BACKENROTH R: Amyloidosis induced end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene. Ann Rheum Dis 2001; 60: 146-9
21. BRIK R, SHINAWI M, KASINETZ L, GERSHONI-BARUCH R: The musculoskeletal manifestations of familial Mediterranean fever in children genetically diagnosed with the disease. Arthritis Rheum 2001; 44: 1416-9.
22. OZEN S, KARAASLAN Y, OZDEMIR O et al.: Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol 1998; 25: 2445-9.
23. OZDOGAN H, KASAPCOPUR O, ARISOY N: Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol 1999; 26: 1638-9.
24. KHUFFASH FA, MAJEED HA, LUBANI MM, NAJDI KN, GUNAWARDANA SS, BUSHNAQ R: Epidemiology of juvenile chronic arthritis and other connective tissue diseases among children in Kuwait. Ann Trop Paediatr 1990; 10: 255-9.
25. GEDALIA A, ADAR A, GORODISHER R: Familial Mediterranean Fever in children. J Rheumatol 1992; 19: 1-9.
26. RABINOVICH E, LIVNEH A, LANGEVITZ P, SHINAR E, ZACKS N, SHINAR Y: Familial Mediterranean Fever gene (MEFV) mutations and rheumatoid arthritis: a severe combination. Clin Exp Rheumatol 2002; 20 (Suppl. 26): A16.
27. CHIKANZA IC: Juvenile rheumatoid arthritis: therapeutic perspectives. Paediatr Drugs 2002; 4: 335-348.
28. TAKEI S, GROH D, BERNSTEIN B, SHAHAM B, GALLAGHER K, REIFF A: Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis. J Rheumatol 2001; 28: 1677-80.